Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301)

  • Ychou M
  • Hohenberger W
  • Thezenas S
  • et al.
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Ychou, M., Hohenberger, W., Thezenas, S., Navarro, M., Gascon, P., Bokemeyer, C., … Santoro, A. (2008). Randomized phase III trial comparing infused 5-fluorouracil/folinic acid (LV5FU) versus LV5FU+irinotecan (LV5FU+IRI) as adjuvant treatment after complete resection of liver metastases from colorectal cancer (LMCRC). (CPT-GMA-301). Journal of Clinical Oncology, 26(15_suppl), LBA4013–LBA4013. https://doi.org/10.1200/jco.2008.26.15_suppl.lba4013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free